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The Consultation reached a general consensus on several
important issues. First, that universal salt iodisation‡ (USI)
remains the key strategy to eliminate iodine deficiency
disorders. Second, that where USI has been effective for at
least 2 years, with salt adequately iodised and consumed by
more than 90% of the population1, it can be reasonably
expected that the iodine needs of women of child-bearing
age and pregnant and lactating women are covered by their
diet, and that the iodine stored in the thyroid gland is
sufficient to ensure adequate hormone synthesis and
secretion. Third, that iodised salt may not provide enough
iodine to meet a child’s needs during complementary
feeding, especially if the mother is only marginally iodine
sufficient, unless complementary foods are fortified with
iodine. It may be necessary therefore to give additional
iodine tomakesure that requirements aremetuntil such time
as the child starts to eat the normal family food. Finally, there
was consensus that monitoring of both iodised salt quality
and iodine nutrition are important to ensure that an optimal
state of iodine nutrition is reached and then sustained.
The Consultation made several specific recommen-
dations concerning requirements, indicators and strategies
to control iodine deficiency disorders in pregnant and
lactating women, and in children less than 2-years-old.
Iodine requirements
The starting point for the Technical Consultation was the
current FAO/WHO recommended iodine intakes2 and
whether the amounts were sufficient to prevent brain
damage or thyroid function disorders due to an iodine
deficiency during pregnancy, lactation and the first 2 years
of life. A recommended nutrient intake§ (RNI) is typically
set at an amount that meets the needs of almost all
apparently healthy individuals in a specified sex and age
group. Because of the lack of data on what comprised a
sufficient intake, the Consultation estimated the needs of
each group by applying what is known about the
efficiency with which iodine is absorbed from the gut,
the estimated metabolic needs, and the typical daily losses
in the faeces and urine, taking into account increased
glomerular filtration in pregnant women. Based on these
assumptions, the proposed intakes are shown in Table 1.
Pregnancy
The Technical Consultation proposed to increase the
current FAO/WHO RNI for iodine during pregnancy2 from
200 to 250mg day21 (Table 1). A daily intake greater than
500mg day21 is not necessary as it would not provide any
additional benefit for health and theoretically may be
associated with impaired thyroid function2,3. However, the
scientific evidence for this is weak because the risk is
related to the history of iodine nutrition in the specific
population before the correction of an iodine deficiency,
and the risk is greater in formerly iodine deficient
populations. Nevertheless, it was considered important
to monitor the risk of thyroid disease due to an excessive
consumption of iodine, as well as due to deficiency.
Lactation
During lactation, the physiology of thyroid hormone
production and urinary iodine (UI) excretion returns to
normal, but iodine is concentrated in the mammary gland
for excretion in breast milk. Thus, using the UI
concentration to estimate intake may lead to an under-
estimate of requirements. But because of the need to
ensure that the infant gets enough iodine from breast milk
to build reserves in the thyroid gland, it was recommended
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that lactating women should continue to consume 250mg
of iodine per day This also represents an increase in the
recommended intake of iodine by 50mg day21 compared
with the previous RNI2. A daily intake greater than
500mg day21 is not necessary as it would not provide any
additional benefit for health and theoretically may be
associated with impaired thyroid function2,4
Children less than 2-years-old
For children less than 2-years-old, the previously
recommended iodine intake of 90mg day21 remains
the same2.Therewasnoattempt toproposea recommended
iodine intake for preterm infants because of the lack of data.
Indicators to assess iodine status and monitor
impact
Most of the iodine absorbed by the body is eventually
excreted in the urine, although there may be small losses
in faeces. Although the concentration of iodine in the
urine of an individual can vary diurnally and from day-to-
day, the concentration of iodine in spot or casual samples
of urine taken from an adequate sample of schoolchildren
has been shown to be a reliable biochemical marker of
recent dietary intake by the general population of the
same area when measured using recommended methods1.
For this reason, the Consultation proposed that the median
UI concentration was the best indicator to use in
population surveys to assess the iodine nutrition of
pregnant and lactating women, and of young children less
than 2-years-old. However, further studies are required to
provide better support for this statement (see below).
Moreover, this indicator should not be used for the
purposes of individual diagnosis and treatment. As an
indicator of iodine intake, median UI concentration does
not provide direct information about thyroid function.
However, a low median UI concentration indicates that a
population is at risk of developing thyroid disorders.
If it is assumed that 90% of iodine intake is excreted in
the urine during pregnancy and that the average volume
of urine is 1.5 l day21, then of every 100mg of iodine
ingested, 90mg is excreted in urine at a concentration of
60mg l21. This can be used as the basis to estimate iodine
intake from the median iodine concentration in the urine
of pregnant women. The median concentration of iodine
in the urine of samples of children less than 2-years-old
could also be used to assess their iodine intake, and thus
their iodine status, using the same calculation as for
pregnant women, but assuming an average volume of
urine of 300–500 ml day21. The main problem lies in
collecting urine samples from this age group.
The Technical Consultation recommended that iodine
status should be assessed in surveys conducted every 3–5
years using methods that have been well described1.
Table 2 shows the median UI concentrations proposed
to classify pregnant women, lactating women and children
aged 0–2-years-old into categories of iodine intake.
In countries or regions in which systematic neonatal
screening for congenital hypothyroidism is done using the
concentration in blood of thyroid-stimulating hormone
(TSH), an elevated concentration of TSH reflects an
insufficient supply of maternal and/or foetal thyroid
hormone to the developing brain and indicates a risk of
irreversible brain damage5. However, the Consultation
recognised that the use of serum TSH concentration as an
indicator needs further validation to establish and then
standardise when and how to collect blood samples after
birth, and more data are required to establish a threshold
to interpret the results.
Strategies to control iodine deficiency in pregnant
and lactating women, and in children between birth
and 24 months of age
Country by category
Where iodine deficiency is a public health problem,
countries can be divided broadly into three categories
based on national salt iodisation coverage.
. Category 1. Countries or regions within countries in
which iodine deficiency is under control in a sustained
way because salt iodisation has been effective for more
than 2 years. This is indicated by the fact that iodised salt
is consumed by more than 90% of households and that
Table 2 The median or range in urinary iodine (UI) concentrations
used to categorise the iodine intake of pregnant women, lactating
women and children less than 2-years-old.
Population group
Median UI
concentration
(mg l21)
Category of
iodine intake
Pregnant women ,150 Insufficient
150–249 Adequate
250–499 More than adequate
$500 No added health
benefit expected
Lactating womena ,100 Insufficient
$100 Adequate
Children less than
2-years-old
,100 Insufficient
$100 Adequate
a In lactating women, the figures for median UI are lower than the iodine
requirements because of the iodine excreted in breast milk.
Table 1 The daily recommended nutrient intake (RNI) for iodine
proposed for pregnant and lactating women, and children less
than 2-years-old, and the daily intake that is considered should
not to be exceeded.
Population group
Recommended
iodine intake
(mg day21)
Level of iodine intake beyond
which no added health benefit
can be expected (mg day21)
Pregnant women 250 .500
Lactating women 250 .500
Children less than
2-years-old
90 .180
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iodine nutrition is optimal according to WHO criteria,
including in pregnant women and children less than
2-years-old1.
. Category 2. Countries or regions within countries in
which not all salt is iodised, salt iodisation is not
regulated, or the distribution of iodised salt is uneven or
has lapsed so that less than 90% of the households
consume iodised salt and iodine nutrition is inadequate.
. Category 3. Countries or regions within countries in
which iodised salt is either not available or available only
to a negligible extent, either because the distribution
system is weak or because an emergency has severely
disrupted iodised salt supplies. In this category, it is
assumed that less than 20% of the households consume
iodised oil and iodine nutrition is inadequate.
Table 3 shows thresholds of median UI concentration
that could be used to help decide into which category a
country—or a geographical or administrative region
within a country—falls.
This categorisation is proposed because it is the easiest
one to apply, given the data currently available in most
countries. However, the Consultation recognised that it
has limitations as the prevalence of households reached by
iodised salt at a national level may mask variations within
the countries among regions or districts: some may have
achieved USI, but this may not be the case at national level
while some regions or districts may not have reached USI
although the country has. In other words, the policy on
iodine supplementation for pregnant women and young
children should, as much as possible, be adjusted to
take into account such variations within the country. This
may require an assessment of iodised salt coverage
prior to designing a programme of supplementation.
Recommended approaches to give additional
iodine to pregnant and lactating women, and to
children less than 2-years-old
There are two main approaches to giving supplementary
iodine: either on a daily basis, typically using potassium
iodide, or on an annual basis, using a slowly released iodine
preparation such as iodised oil. The approachused depends
on the accessibility of the populations to be reached.
Moreover, given the fact that the dietary iodine content may
vary indifferent populations, the amountof iodinegiven as a
supplement should be based on a prior assessment of the
current iodine intake by the population so that the total
amount of daily iodine consumed, including the iodine
supplement, does not exceed the RNI (see Table 1).
Category 1. Countries or regions within countries with
effective and sustained salt iodisation (more than 90% of
the households consumed iodised salt)
In the first group of countries or regions within countries,
the population is considered to be iodine sufficient; so
pregnant and lactating women have no need for iodine
supplements, nor do children aged 0–24-months-old
require them. Indeed, the amount of iodine stored in the
thyroid of a child at birth, when added to the iodine intake
from the mother’s breast milk, is likely to be sufficient to
meet a child’s need for iodine for the first 6 months of life
and even up to 24 months of age.
Category 2. Countries or regions within the countries with
uneven or lapsed iodised salt distribution (the proportion
of the households consuming iodised salt is between 20
and 90%)
In the second group of countries or regions within
countries, iodine intakes are generally insufficient to meet
iodine requirements and do not protect the foetus
and young child against the adverse effects of iodine
deficiency, especially on brain development. Therefore,
while measures should be taken to ensure that effective USI
is implemented in conjunction with a programme of public
education, iodine supplements are needed by pregnant
and lactating women. They are also needed by women of
child-bearing age to allow them to start pregnancy with
enough stored iodine to meet both their own needs and the
needs of their foetus. On the other hand, in children from
birth to 24 months of age, although iodised oil can be
considered as safe to give, there are few data on its efficacy
in this age group; so additional iodine intake should be
given through breast milk from a mother supplemented
with iodine and, in elder children, through complementary
foods fortified with iodine. The following is recommended:
. Women of child-bearing age should be given a daily oral
dose of iodine as potassium iodide, so that the total
iodine intake meets the RNI of 150mg of iodine per
day2; or a single annual oral dose of 400 mg of iodine as
iodised oil should be given. At the same time, measures
should be taken to educate this group about why and
how to prevent iodine deficiency.
. Pregnant and lactating women should be given a daily
oral dose of iodine as potassium iodide so that the total
iodine intake meets the RNI of 250mg of iodine per day
(Table 1), either alone or in combination with other
mineral and vitamin supplements; or a single annual
oral dose of 400 mg of iodine as oral iodised oil should
be given. Iodine supplements should not be given if the
mother has already received iodised oil either during
her current pregnancy or up to 3 months before her
current pregnancy started.
. Children 0–6 months of age should be given additional
iodine to meet their daily requirements through breast
milk. This implies that the child is exclusively breast-fed
and the mother received iodine supplements during
pregnancy or lactation as indicated in the above
paragraphs.
. Children 7–24 months of age should be given
additional iodine through complementary foods
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Table 3 Strategies to control iodine deficiency in pregnant and lactating women, and in children between birth and 24 months of agea.
Status of salt iodisation in country
or region within country
Approaches to give additional iodine to each population group
Women of reproductive age Pregnant and lactating women Children 0–6 months of age Children 7–24 months of age
Category 1 (more than 90%
households using iodised salt)
median UIb . 100mg l21
a) USI a) USI a) Exclusive breast-feeding. USI Ensure that complementary
foods are fortified with iodine.
Category 2 (Between 20 and
90% of households using
iodised salt) 20mg l21 ,median
UIb , 100mg l21
a) Give iodine supplement:
As a daily oral dose of iodine
as potassium iodide so that
the total iodine intake is
1 RNI or 150mg of iodine
per day or as a single annual
oral dose of 400mg of iodine
as iodised oil
a) Give iodine supplement: As a daily oral dose
of iodine as potassium iodide so that the total
iodine intake is 1 RNI or 250mg of iodine per
day, either alone or combined with other
minerals and vitamins or as a single annual
oral dose of 400mg of iodine as iodised oil.
b) Iodine supplements should not
be given if the mother has received iodised
oil during her current pregnancy or up to
3months before her pregnancy started
a) Exclusive breast-feeding.
b) Measure should be taken so
that the mother received
iodine supplements during
pregnancy and lactation
a) Give additional iodine as soon
as possible after 6months through
complementary foods fortified
with iodine. b) Breast-feeding
should be sustained
Category 3 (less than 20% of
households using iodised salt)
median UIb , 20mg l21
a) Give iodine supplement:
As a single annual oral
dose of 400mg of iodine as
iodised oil or if feasible, as
a daily oral dose of iodine
as potassium iodide so that
the total iodine intake is
1 RNI or 150mg of iodine
per day
a) Give iodine supplement: As a single
annual oral dose of 400mg of iodine
as iodised oil or if feasible, as a daily
oral dose of iodine as potassium iodide
so that the total iodine intake is 1 RNI
or 250mg of iodine per day, either alone
or combined with other minerals and vitamins.
b) Iodine supplements should not be
given if the mother has already received
iodised oil during her current pregnancy or up
to 3months before her pregnancy started
a) Exclusive breast-feeding.
b) Measure should be taken so
that the mother received iodine
supplements during pregnancy
and lactation
a) Give additional iodine as soon
as possible after 6months through
complementary foods fortified
with iodine. b) Breast-feeding
should be sustained
a The strategies should be adapted according to local conditions.
b UI stands for urinary iodine.
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fortified with iodine. Breast-feeding should be
sustained.
Category 3. Countries or regions within the countries with
weak or negligible iodised salt distribution (less than 90%
of the households consumed iodised salt)
In the third group of countries or regions within countries,
despite their poor iodine nutrition, populations do not
receive any additional iodine in the form of supplements
or iodised salt. Such populations should be given
supplements focussing on pregnant women, lactating
women and women of child-bearing age. Since such
people may live in remote areas or may experience an
emergency, it may not be possible to deliver a daily iodine
supplement, so giving iodised oil may be a better option.
In children from birth to 24 months of age, for the reasons
given in the previous paragraph, additional iodine intake
should be given through breast milk from a mother
supplemented with iodine and, in elder children, through
complementary foods fortified with iodine. However,
there may be some situations where the child is not breast-
fed; given the heath consequences of iodine deficiency,
iodine supplementation should be considered for such
children. Moreover, strong efforts should be made to
establish or reinstitute USI and to ensure that iodised salt is
distributed widely. The following is recommended:
. Women of child-bearing age should be given a single
annual oral dose of 400 mg of iodine as iodised oil; or, if
feasible, a daily oral dose of iodine as potassium iodide
should be given so that the total iodine intake meets the
RNI of 150mg of iodine per day. At the same time,
measures should be taken to educate this group about
why and how to prevent an iodine deficiency.
. Women who are currently pregnant or lactating should
be given a single annual oral dose of 400 mg of iodine as
iodised oil; or, if feasible, a daily oral dose of iodine as
potassium iodide should be given so that the total
iodine intake meets the RNI of 250mg of iodine per day.
Iodine supplements should not be given to women who
have already been given iodised oil during her current
pregnancy or up to 3 months before her current
pregnancy started.
. Children 0–6 months of age should be given additional
iodine to meet their daily requirements through breast
milk. This implies that the child is exclusively breast-fed
and the mother received iodine supplements during
pregnancy or lactation as indicated in the above
paragraphs. Iodine supplementation should be con-
sidered where the child is not breast-fed.
. Children 7–24 months of age should be given
additional iodine through complementary foods for-
tified with iodine. Breast-feeding should be sustained.
These recommendations are summarised in Table 3.
These dosages are considered to be safe to administer6.
Priorities for research
Several priorities for research were identified concerning
the physiology and metabolism of iodine during
pregnancy and early infancy. A particular emphasis was
placed on the importance of a multidisciplinary approach
involving nutritionists, endocrinologists, obstetricians and
paediatricians. Specific studies were proposed on:
. Risk factors for iodine deficiency and its functional
consequences including:
* the relationships between a high intake of iodine and
thyroid disease and function, especially in neonates
and infants;
* breast milk iodine concentration;
* the influence of smoking on iodine status and breast
milk iodine concentration;
* the impact of iodine supplements on cognitive
development and intellectual outcomes through
randomised, controlled trials; and
* the metabolic interactions between iodine and
other micronutrients in the situation of iodine
deficiency.
. Indicators and assessment of iodine status including:
* the identification of the best indicators to assess
iodine nutrition and monitor the impact of interven-
tions to control iodine deficiency during pregnancy,
lactation and the first 2 years of infancy;
* the relationship between the iodine status of school-
children and the iodine status of pregnant women in
the same location, to see whether school-age
children, the usual indicator group, are the most
appropriate group to reflect the iodine status of
pregnant women and young children less than
2 years of age;
* the median UI concentration that corresponds to an
excessive iodine intake in pregnant and lactating
women, and children less than 2 years of age;
* the prevalence of iodine deficiency in pregnant
and lactating women, and children less than 2 years
of age; and
* standardisation of the measurement and interpret-
ation of serum TSH in neonates.
. Approaches to controlling iodine deficiency including:
* strategies to advocate the iodisation of salt and to
market iodised salt;
* factors that hamper the consumption of iodised salt,
including the effect of a diminishing salt intake due to
the risks of hypertension;
* complementary strategies—in addition to iodised
salt—to provide iodine to children 0–24 months of
age, in particular, during the complementary feeding
period;
* the bioavailability of iodine as iodised oils and the
optimum dose of iodised oil to give to pregnant
women, lactating women and infants; and
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* the development of new pharmaceutical prep-
arations of iodine.
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